Aditxt, Inc. (NASDAQ:ADTX – Free Report) shares are set to reverse split on the morning of Wednesday, October 2nd. The 1-40 reverse split was announced on Friday, September 27th. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, October 1st.
Aditxt Stock Performance
NASDAQ ADTX opened at $0.16 on Friday. Aditxt has a twelve month low of $0.16 and a twelve month high of $24.00. The stock’s 50-day simple moving average is $0.81 and its two-hundred day simple moving average is $1.76.
Aditxt (NASDAQ:ADTX – Get Free Report) last announced its quarterly earnings data on Monday, August 19th. The company reported ($4.19) earnings per share (EPS) for the quarter. The company had revenue of $0.04 million for the quarter. Aditxt had a negative net margin of 5,016.31% and a negative return on equity of 615.43%.
Aditxt Company Profile
Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.
Featured Stories
- Five stocks we like better than Aditxt
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- What Does Downgrade Mean in Investing?
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- What Is WallStreetBets and What Stocks Are They Targeting?
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
